• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Considerations on designing clinical trials to evaluate the place of new antiepileptic drugs in the treatment of newly diagnosed and chronic patients with epilepsy.

出版信息

Epilepsia. 1998 Jul;39(7):799-803. doi: 10.1111/j.1528-1157.1998.tb01167.x.

DOI:10.1111/j.1528-1157.1998.tb01167.x
PMID:9670910
Abstract
摘要

相似文献

1
Considerations on designing clinical trials to evaluate the place of new antiepileptic drugs in the treatment of newly diagnosed and chronic patients with epilepsy.关于设计临床试验以评估新型抗癫痫药物在新诊断和慢性癫痫患者治疗中的地位的思考。
Epilepsia. 1998 Jul;39(7):799-803. doi: 10.1111/j.1528-1157.1998.tb01167.x.
2
Postmarketing surveillance of new antiepileptic drugs: the tribulations of trials.
Epilepsia. 2002 Sep;43(9):951-5. doi: 10.1046/j.1528-1157.2002.24302.x.
3
Prototype antiepileptic drug clinical development plan.抗癫痫药物原型临床开发计划。
Epilepsia. 1993 Nov-Dec;34(6):1075-84. doi: 10.1111/j.1528-1157.1993.tb02136.x.
4
Sources of variability in clinical trials of new drugs for epilepsy.癫痫新药临床试验中的变异性来源。
Epilepsy Res Suppl. 1993;10:157-66.
5
Antiepileptic drugs, clinical trials, and the marketplace.
Lancet. 1996 Mar 23;347(9004):777-9. doi: 10.1016/s0140-6736(96)90863-6.
6
Clinical trials performed for the new drug approval process in the United States: standard methods and alternative methods.在美国为新药审批流程开展的临床试验：标准方法与替代方法。
Epilepsy Res Suppl. 1993;10:31-44.
7
Protocol design.
Epilepsy Res Suppl. 1993;10:107-13.
8
Monotherapy trials of new antiepileptic drugs.新型抗癫痫药物的单药治疗试验。
Epilepsia. 1997;38 Suppl 9:S21-31. doi: 10.1111/j.1528-1157.1997.tb05201.x.
9
External influences on protocol design.对方案设计的外部影响。
Epilepsy Res Suppl. 1993;10:115-24.
10
Patient recruitment and compliance issues in clinical trials.
Epilepsy Res Suppl. 1993;10:211-22.

引用本文的文献

1
Guide to evaluating performance of prediction models for recurrent clinical events.复发性临床事件预测模型性能评估指南
Diagn Progn Res. 2025 Mar 17;9(1):6. doi: 10.1186/s41512-025-00187-7.
2
Effectiveness and tolerability of lacosamide in children with drug resistant epilepsy.拉科酰胺治疗耐药性癫痫患儿的有效性和耐受性
Epilepsy Behav Rep. 2022 Nov 14;21:100574. doi: 10.1016/j.ebr.2022.100574. eCollection 2023.
3
First-line levetiracetam versus enzyme-inducing antiseizure medication in glioma patients with epilepsy.一线左乙拉西坦与酶诱导抗癫痫药物治疗脑胶质瘤伴发癫痫。
Epilepsia. 2023 Jan;64(1):162-169. doi: 10.1111/epi.17464. Epub 2022 Nov 24.
4
Anti-seizure efficacy and retention rate of carbamazepine is highly variable in randomized controlled trials: A meta-analysis.卡马西平在随机对照试验中的抗惊厥疗效和保留率差异很大：一项荟萃分析。
Epilepsia Open. 2022 Dec;7(4):556-569. doi: 10.1002/epi4.12644. Epub 2022 Aug 30.
5
Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.抗癫痫药物单药治疗癫痫：一项个体参与者数据的网络荟萃分析。
Cochrane Database Syst Rev. 2022 Apr 1;4(4):CD011412. doi: 10.1002/14651858.CD011412.pub4.
6
Anti-Seizure Medication Treatment of Benign Childhood Epilepsy With Centrotemporal Spikes: A Systematic Review and Meta-analysis.伴有中央颞区棘波的儿童良性癫痫的抗癫痫药物治疗：一项系统评价和荟萃分析。
Front Pharmacol. 2022 Mar 10;13:821639. doi: 10.3389/fphar.2022.821639. eCollection 2022.
7
Sulthiame monotherapy for epilepsy.硫喷妥钠单药治疗癫痫。
Cochrane Database Syst Rev. 2021 Sep 23;9(9):CD010062. doi: 10.1002/14651858.CD010062.pub3.
8
PERMIT study: a global pooled analysis study of the effectiveness and tolerability of perampanel in routine clinical practice.PERMIT 研究：一项在常规临床实践中评估吡仑帕奈有效性和耐受性的全球性汇总分析研究。
J Neurol. 2022 Apr;269(4):1957-1977. doi: 10.1007/s00415-021-10751-y. Epub 2021 Aug 24.
9
The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.SANAD II 研究：丙戊酸钠与左乙拉西坦治疗新诊断的全面性和不可分类癫痫的有效性和成本效益：一项开放标签、非劣效性、多中心、4 期、随机对照试验。
Lancet. 2021 Apr 10;397(10282):1375-1386. doi: 10.1016/S0140-6736(21)00246-4.
10
The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.SANAD II 研究：左乙拉西坦、唑尼沙胺或拉莫三嗪治疗新诊断局灶性癫痫的有效性和成本效益：一项开放标签、非劣效性、多中心、4 期、随机对照试验。
Lancet. 2021 Apr 10;397(10282):1363-1374. doi: 10.1016/S0140-6736(21)00247-6.